Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Nafarelin Acetate Hydrate (jan)
2. Synarel (tn)
3. Chebi:7446
4. Bcp19032
5. Ft-0642036
6. D00990
7. Rs 94991 298;rs-94991-298;rs94991298
Molecular Weight | 1400.5 g/mol |
---|---|
Molecular Formula | C68H89N17O16 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 18 |
Rotatable Bond Count | 33 |
Exact Mass | 1399.66731982 g/mol |
Monoisotopic Mass | 1399.66731982 g/mol |
Topological Polar Surface Area | 513 Ų |
Heavy Atom Count | 101 |
Formal Charge | 0 |
Complexity | 2760 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 9 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Synarel |
PubMed Health | Nafarelin (Into the nose) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | SYNAREL (nafarelin acetate) Nasal Solution is intended for administration as a spray to the nasal mucosa. Nafarelin acetate, the active component of SYNAREL Nasal Solution, is a decapeptide with the chemical name: 5-oxo-L-prolyl-L-histidyl-L-tryptoph... |
Active Ingredient | Nafarelin acetate |
Dosage Form | Spray, metered |
Route | Nasal |
Strength | eq 0.2mg base/spray |
Market Status | Prescription |
Company | Gd Searle |
2 of 2 | |
---|---|
Drug Name | Synarel |
PubMed Health | Nafarelin (Into the nose) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | SYNAREL (nafarelin acetate) Nasal Solution is intended for administration as a spray to the nasal mucosa. Nafarelin acetate, the active component of SYNAREL Nasal Solution, is a decapeptide with the chemical name: 5-oxo-L-prolyl-L-histidyl-L-tryptoph... |
Active Ingredient | Nafarelin acetate |
Dosage Form | Spray, metered |
Route | Nasal |
Strength | eq 0.2mg base/spray |
Market Status | Prescription |
Company | Gd Searle |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Nafarelin Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nafarelin Acetate manufacturer or Nafarelin Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nafarelin Acetate manufacturer or Nafarelin Acetate supplier.
PharmaCompass also assists you with knowing the Nafarelin Acetate API Price utilized in the formulation of products. Nafarelin Acetate API Price is not always fixed or binding as the Nafarelin Acetate Price is obtained through a variety of data sources. The Nafarelin Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Synarel manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Synarel, including repackagers and relabelers. The FDA regulates Synarel manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Synarel API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Synarel manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Synarel supplier is an individual or a company that provides Synarel active pharmaceutical ingredient (API) or Synarel finished formulations upon request. The Synarel suppliers may include Synarel API manufacturers, exporters, distributors and traders.
click here to find a list of Synarel suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Synarel DMF (Drug Master File) is a document detailing the whole manufacturing process of Synarel active pharmaceutical ingredient (API) in detail. Different forms of Synarel DMFs exist exist since differing nations have different regulations, such as Synarel USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Synarel DMF submitted to regulatory agencies in the US is known as a USDMF. Synarel USDMF includes data on Synarel's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Synarel USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Synarel suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Synarel Drug Master File in Japan (Synarel JDMF) empowers Synarel API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Synarel JDMF during the approval evaluation for pharmaceutical products. At the time of Synarel JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Synarel suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Synarel as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Synarel API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Synarel as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Synarel and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Synarel NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Synarel suppliers with NDC on PharmaCompass.
Synarel Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Synarel GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Synarel GMP manufacturer or Synarel GMP API supplier for your needs.
A Synarel CoA (Certificate of Analysis) is a formal document that attests to Synarel's compliance with Synarel specifications and serves as a tool for batch-level quality control.
Synarel CoA mostly includes findings from lab analyses of a specific batch. For each Synarel CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Synarel may be tested according to a variety of international standards, such as European Pharmacopoeia (Synarel EP), Synarel JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Synarel USP).